HEPATITIS C ANTIVIRALS

RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

Induction of exon skipping in eukaryotic cells

Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer

Duplex oligonucleotides with enhanced functionality in gene regulation

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE HAMP GENE

ANTISENSE COMPOUNDS HAVING ENHANCED ANTI-MICRORNA ACTIVITY

HEPATITIS C ANTIVIRALS

vWF aptamer formulations and methods for use

MIR-150 FOR THE TREATMENT OF BLOOD DISORDERS

2'-Modified Oligonucleotides

Modified short interfering RNA

RNA antagonist compounds for the modulation of PIK3CA expression

Modulation of eIF4E expression

RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA)

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

Methods to reprogram splice site selection in pre-messenger RNAs

Interfering RNA molecules

RNA sequence-specific mediators of RNA interference

Small internally segmented interfering RNA

METHOD OF TREATING NEURODEGENERATIVE DISEASE

Methods and compositions involving miRNA and miRNA inhibitor molecules

Complex for transferring an anionic substance into a cell

Nucleic acid capable of binding to immunoglobulin G and use thereof

Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R)

Novel siRNAS and methods of use thereof

DBAIT and uses thereof

Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field

RNA INTERFERENCE MEDIATED INHIBITION OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNAi inhibition of alpha-ENaC expression

RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)

Antiviral oligonucleotides targeting viral families

Novel siRNAS and methods of use thereof

RNA Interference Mediating Small RNA Molecules

Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics

RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

Compositions and methods for inhibiting expression of a gene from the Ebola

Cell transfecting formulations of small interfering RNA related compositions and methods of making and use

Transcription factor decoy

RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (SINA)

RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/ REL-A GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF ANGIOPOIETIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)

Methods and compositions for regulating cell cycle progression via the miR-106B family

Tripartite RNAi constructs

NUCLEIC ACIDS HYBRIDIZABLE TO MICRO RNA AND PRECURSORS THEREOF

Antisense microRNA and uses therefor

RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF MYOSTATIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)

Antiviral oligonucleotides

RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acid (siNA)

RNAi modulation of SCAP and therapeutics uses thereof

Compositions and methods to stack multiple nucleotide sequences of interest in the genome of a plant

Enhanced retinal delivery of a nucleic acid through iontophoresis

Sequence-specific inhibition of small RNA function

Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics

Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure

Metabolic profile directed aptamer medicinal chemistry

Compositions and methods for inhibiting expression of a gene from the JC virus

Stabilized Aptamers to Platelet Derived Growth Factor and their Use as Oncology Therapeutics

Oligonucleotide modulation of cell adhesion

Antiviral oligonucleotides targeting HBV

DOUBLE-STRANDED LOCKED NUCLEIC ACID COMPOSITIONS

RNA interference in respiratory epithelial cells

RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

MODIFICATION OF DOUBLE-STRANDED RIBONUCLEIC ACID MOLECULES

Nucleic Acid Ligands Specific to Immunoglobuline E and Their Use as Atopic Disease Therapeutics

Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions

Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial

Tandem siRNAS

NUCLEIC ACID COMPOUNDS FOR INHIBITING AKT GENE EXPRESSION AND USES THEREOF

Synthetic agonists of TLR9

Pharmaceutical Composition Containing Meltrin Antagonist

Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases

Oligonucleotide complex compositions and methods of use as gene alteration tools

Lipids, lipid complexes and use thereof

RNA interference mediating small RNA molecules

Chimeric Gapped Oligomeric Compounds

Norovirus detection, methods and compositions therefor

RNA Interference Mediated Inhibition of Gene Expression Using Short Interfering Nucleic Acid (siNA)

Modified siRNA molecules and uses thereof

Modified polynucleotides for reducing off-target effects in RNA interference

Materials and methods for treatment of cancer

Methods and compositions for reducing viral genome amounts in a target cell

Oligonucleotide-containing pharmacological compositions and their use

Compositions and methods for inhibiting expression of Huntingtin gene

Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant

Induction of exon skipping in eukaryotic cells

Platelet derived growth factor (PDGF) nucleic acid ligand complexes

Modulation of T cell signaling threshold and T cell sensitivity to antigens

Methods for the Delivery of Oligomeric Compounds

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

Synthetic siRNA compounds and methods for the downregulation of gene expression

Methods and compositions involving miRNA and miRNA inhibitor molecules

NUCLEIC ACID MODULATION OF TOLL-LIKE RECEPTOR-MEDIATED IMMUNE STIMULATION

Methods and compositions involving miRNA and miRNA inhibitor molecules

Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8

Oligonucleotide-containing pharmacological compositions and their use

Oligonucleotide-containing pharmacological compositions and their use

Modulators of coagulation factors

Positionally modified siRNA constructs

RNA sequence-specific mediators of RNA interference

Modulators of coagulation factors with enhanced stability

Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation

Compositions and methods for the treatment of muscle wasting

Compositions and methods for inhibiting expression of the PCSK9 gene

Lipophilic conjugated iRNA agents

Compositions and methods for inhibiting expression of IKK-B gene

MODULATION OF GENE EXPRESSION USING DNA-RNA HYBRIDS

Duplex oligonucleotide complexes and methods for gene silencing by RNA interference

miRNA of HSV-LAT and uses thereof

Therapeutic uses of inhibitors of RTP801L

G-rich polynucleotides as a novel therapeutic for the treatment of huntington's disease

Modulators of pharmacological agents

Methods and compositions involving miRNA and miRNA inhibitor molecules

POLYCYCLIC SUGAR SURROGATE-CONTAINING OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN GENE MODULATION

RETROGRADE TRANSPORT OF SIRNA AND THERAPEUTIC USES TO TREAT NEUROLOGIC DISORDERS

Polycationic compositions for cellular delivery of polynucleotides

2'-MODIFIED OLIGONUCLEOTIDES

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes

Short antisense compounds with gapmer configuration

RNAi modulation of TGF-beta and therapeutic uses thereof

Antisense modulation of kinesin-like 1 expression

Pharmaceutical Compositions and Methods for Reducing Body Fat

COMPLEXES AND METHODS OF FORMING COMPLEXES OF RIBONUCLEIC ACIDS AND PEPTIDES

Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial

Human RNase H1 oligonucleotide compositions thereof

Anti-microRNA oligonucleotide molecules

Compositions and methods for inhibiting expression of Eg5 gene

Oligonucleotide and the use thereof for modulating an isoform C beta-1 protein-kinase in the form of a skin depigmentation agent

Compositions and methods for modulation of Mcl-1 expression

DOUBLE STRANDED NUCLEIC ACID MOLECULES TARGETED TO IL-4 RECEPTOR ALPHA

Modulation of telomere length by oligonucleotides having a G-core sequence

Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (Sars) Gene Expression Using Short Interfering Nucleic Acid

Stabilized siRNAs as transfection controls and silencing reagents

COMPOSITIONS AND METHODS EMPLOYING UNIVERSAL-BINDING NUCLEOTIDES FOR TARGETING MULTIPLE GENE VARIANTS WITH A SINGLE siRNA DUPLEX

Compositions and methods for non-parenteral delivery of oligonucleotides

Compounds and Methods for Rna Interference of the P65 Subunit of Nf-Kappa-B

Soluble TNF receptors and their use in treatment of disease

Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity

siRNA silencing of influenza virus gene expression

Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof

Data correction apparatus, data correction method, magnetic resonance imaging apparatus and X-ray CT apparatus

RNA interference mediated inhibition of histone deacetylase (HDAC) gene expression using short interfering nucleic acid (siNA)

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Rna interference mediated inhibition of nogo and nogo receptor gene expression using short interfering nucleic acid (sina)

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Protected monomers

Antisense IAP nucleobase oligomers and uses thereof

MODIFIED POLYNUCLEOTIDES FOR USE IN RNA INTERFERENCE

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Antisense oligonucleotides (ODN) against Smad7 and uses in medical field thereof

Modified polynucleotides for use in rna interference

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)

Method of treating neurodegenerative disease

Antisense modulation of CD40 expression

RNAi modulation of HIF-1 and therapeutic uses thereof

Antisense IAP oligonucleotides and uses thereof

Antisense IAP nucleobase oligomers and uses thereof

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof

Antisense IAP oligonucleotides and uses thereof

Oligonucleotides targeting prion diseases

Materials and methods for the generation of fully 2′-modified nucleic acid transcripts

Modulation of gene expression by oligomers targeted to chromosomal DNA

Dbait and uses thereof

RNA interference

Modulators of coagulation factors with enhanced stability

Inhibition of histone deacetylase

Splice switch oligomers for TNF superfamily receptors and their use in treatment of disease

Compositions and methods for inhibiting expression of Nav1.8 gene

G-rich polynucleotides for the treatment of Huntington's Disease

Compositions and methods for inhibiting expression of Huntingtin gene

RNA interference mediating small RNA molecules

Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)

Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes

Aptamer medicinal chemistry

Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics

Modulation of eIF4E expression

Pure miRNA Sample Preparation Method

Method and apparatus to facilitate transmission of an encrypted rolling code

Antisense IAP nucleobase oligomers and uses thereof

RNA interference mediated inhibition of 11 beta-hydroxysteroid dehydrogenase-1 (11 beta-HSD-1) gene expression using short interfering nucleic acid siNA

Aptamer therapeutics useful in the treatment of complement-related disorders

RNAi modulation of the Rho-A gene in research models

Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field

iRNA agents targeted to the Rho-A gene

Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)

Antisense IAP nucleobase oligomers and uses thereof

Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)

Small interfering RNA with improved activity

Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies

Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor

Antiviral oligonucleotides having a conserved G4 core sequence

Nucleic acid ligands to integrins

Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Methods and compositions for treating ocular disorders

Dual functional oligonucleotides for use as anti-viral agents

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated ihibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Modulation of apolipoprotein c-III expression

Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics

Combined therapy utilizing reduction of DNA methyltransferase expression and/or activity and interferon

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Rna interference mediated treatment of alzheimer's disease using short interfering nucleic acid (sina)

Oligonucleotide mimetics

RNA interference mediated inhibition of desmoglein gene expression using short interfering nucleic acid (siNA)

Synthesis, deprotection, analysis & purification of RNA & ribozymes

Highly functional short hairpin RNA

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Chemically modified double stranded nucleic acid molecules that mediate RNA interference

Therapeutic uses of inhibitors of RTP801

Delivery of polynucleotide agents to the central nervous system

Antisense modulation of farnesoid X receptor expression

Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics

Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics

Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof

Ribozyme therapy for the treatment of proliferative skin and eye diseases

Modification of MyD88 splicing using modified oligonucleotides

Oligonucleotide inhibitors of MBD2/DNA demethylase and uses thereof

Influenza therapeutic

RNA interference mediated inhibition hairless of (HR) gene expression using short interfering nucleic acid (siNA)

Enzymatic nucleic acid treatment of diseases or conditions related to levels of IKK-gamma and PKR

RNA interference mediated inhibition of histone deacetylase (HDAC) gene expression using short interfering nucleic acid (siNA)

Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure

Antisense oligonucleotide modulation of raf gene expression

RNA interference mediated inhibition of cyclin dependent kinase-2 (CDK2) gene expression using short interfering nucleic acid (siNA)

Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes

Antiviral oligonucleotides

Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes

RNA interference mediated inhibition of MAP kinase gene expression or expression of genes involved in MAP kinase pathway using short interfering nucleic acid (siNA)

Effective and stable DNA enzymes

Apparatus and system having dry gene silencing compositions

Aptamer therapeutics useful in the treatment of complement-related disorders

Synergistic inhibition of VEGF and modulation of the immune response

RNAi modulation of ApoB and uses thereof

Tenascin-C nucleic acid ligands

Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure

Nuclease resistant double-stranded ribonucleic acid

RNA interference in respiratory epitheial cells

Conjugates for use in hepatocyte free uptake assays

Methods to reprogram splice site selection in pre-messenger rnas

Modulators of coagulation factors

Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis

Controlled modulation of the pharmacokinetics and biodistribution of aptamer therapeutics

Oligoribonucleotide derivatives for specific inhibition of gene expression

RNA interference mediated inhibition of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of stromal cell-derived factor-1 (SDF-1) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibtion of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

Cell transfecting formulations of small interfering RNA related compositions and methods of making and use

Aptamer therapeutics useful in the treatment of complement-related disorders

RNA virus expression and replication, methods and uses therefor

Methods and compositions for reducing viral genome amounts in a target cell

RNA interference mediated inhibition of RAS gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)